1. Home
  2. PROK vs SGA Comparison

PROK vs SGA Comparison

Compare PROK & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • SGA
  • Stock Information
  • Founded
  • PROK 2015
  • SGA 1986
  • Country
  • PROK United States
  • SGA United States
  • Employees
  • PROK N/A
  • SGA N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • SGA Broadcasting
  • Sector
  • PROK Health Care
  • SGA Consumer Discretionary
  • Exchange
  • PROK Nasdaq
  • SGA Nasdaq
  • Market Cap
  • PROK 85.5M
  • SGA 74.2M
  • IPO Year
  • PROK N/A
  • SGA 1992
  • Fundamental
  • Price
  • PROK $0.58
  • SGA $13.20
  • Analyst Decision
  • PROK Hold
  • SGA
  • Analyst Count
  • PROK 3
  • SGA 0
  • Target Price
  • PROK $3.50
  • SGA N/A
  • AVG Volume (30 Days)
  • PROK 1.6M
  • SGA 16.2K
  • Earning Date
  • PROK 08-08-2025
  • SGA 08-07-2025
  • Dividend Yield
  • PROK N/A
  • SGA 7.56%
  • EPS Growth
  • PROK N/A
  • SGA N/A
  • EPS
  • PROK N/A
  • SGA 0.55
  • Revenue
  • PROK $306,000.00
  • SGA $111,837,000.00
  • Revenue This Year
  • PROK $54.34
  • SGA N/A
  • Revenue Next Year
  • PROK N/A
  • SGA $4.84
  • P/E Ratio
  • PROK N/A
  • SGA $24.21
  • Revenue Growth
  • PROK N/A
  • SGA N/A
  • 52 Week Low
  • PROK $0.46
  • SGA $10.75
  • 52 Week High
  • PROK $2.59
  • SGA $16.48
  • Technical
  • Relative Strength Index (RSI)
  • PROK 39.22
  • SGA 63.76
  • Support Level
  • PROK $0.54
  • SGA $11.50
  • Resistance Level
  • PROK $0.90
  • SGA $13.38
  • Average True Range (ATR)
  • PROK 0.13
  • SGA 0.56
  • MACD
  • PROK -0.03
  • SGA 0.07
  • Stochastic Oscillator
  • PROK 8.06
  • SGA 61.37

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

Share on Social Networks: